Mick N Mulders
Overview
Explore the profile of Mick N Mulders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crowcroft N, Minta A, Antoni S, Ho L, Perea W, Mulders M, et al.
Rev Panam Salud Publica
. 2024 Dec;
48():e90.
PMID: 39687257
Measles and rubella have long been recognized as priorities for disease prevention because of their devastating consequences for child health; hence, all World Health Organization (WHO) regions currently have a...
2.
Minta A, Ferrari M, Antoni S, Lambert B, Sayi T, Hsu C, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Nov;
73(45):1036-1042.
PMID: 39541251
Measles vaccination effectively prevents measles, a highly contagious disease that can cause severe complications and death and requires high population immunity to interrupt transmission. This report describes measles elimination progress...
3.
Rota P, Evans R, Ben Mamou M, Rey-Benito G, Sangal L, Dosseh A, et al.
Vaccines (Basel)
. 2024 Aug;
12(8).
PMID: 39204069
With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the...
4.
Rachlin A, Hampton L, Rota P, Mulders M, Papania M, Goodson J, et al.
Vaccines (Basel)
. 2024 Aug;
12(8).
PMID: 39203949
Efforts to control and eliminate measles and rubella are aided by high-quality surveillance data-supported by laboratory confirmation-to guide decision-making on routine immunization strategies and locations for conducting preventive supplementary immunization...
5.
Crowcroft N, Minta A, Bolotin S, Cernuschi T, Ariyarajah A, Antoni S, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066457
Measles is a highly infectious disease leading to high morbidity and mortality impacting people's lives and economies across the globe. The measles vaccine saves more lives than any other vaccine...
6.
Hagan J, Crooke S, Gunregjav N, Sowers S, Mercader S, Hickman C, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932425
Mongolia experienced a nationwide measles outbreak during 1 March 2015-31 December 2016, with 49,077 cases reported to the WHO; many were among vaccinated young adults, suggesting a possible role of...
7.
Senin A, Noordin N, Sani J, Mahat D, Donadel M, Scobie H, et al.
PLoS One
. 2024 Mar;
19(3):e0298730.
PMID: 38483868
Introduction: A lateral flow rapid diagnostic test (RDT) enables detection of measles specific immunoglobulin M (IgM) antibody in serum, capillary blood, and oral fluid with accuracy consistent with enzyme immunoassay...
8.
Minta A, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Nov;
72(46):1262-1268.
PMID: 37971951
Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no...
9.
Minta A, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Nov;
71(47):1489-1495.
PMID: 36417303
All six World Health Organization (WHO) regions have committed to eliminating measles.* The Immunization Agenda 2021-2030 (IA2030) aims to achieve the regional targets as a core indicator of impact and...
10.
Basile A, Niedrig M, Lambert A, Meurant R, Brault A, Domingo C, et al.
PLoS Negl Trop Dis
. 2022 Sep;
16(9):e0010770.
PMID: 36067233
Background: Early detection of human yellow fever (YF) infection in YF-endemic regions is critical to timely outbreak mitigation. African National Laboratories chiefly rely on serological assays that require confirmation at...